Skip to content

USH1SON

Pathogenic Variants in Usher Syndrome type 1 Genes: Syndromic Or Non-syndromic? - USH1SON

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57722
Enrollment
20
Registered
2024-12-18
Start date
2025-11-07
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Usher syndrome, retintis pigmentosa Usher syndrome

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
No minimum to 17 Years

Inclusion criteria

Inclusion criteria: - clinically diagnosed congenital hearing loss and bi-allelic variants in genes associated with Usher syndrome type 1, of which at least one variant is classified as (likely) pathogenic - age < 18 years - written informed consent is obtained from: parents (children age 0-11), children and parents (children age 12-15), adolescents (age 16-17)

Exclusion criteria

Exclusion criteria: - Mutations in genes that cause autosomal dominant RP, X-linked RP or presence of biallelic mutations in autosomal recessive RP/retinal dystrophy genes other than Usher genes  - Current vitreous hemorrhage  - History of intraocular surgery  - Current or any history of confirmed diagnosis of glaucoma  - History or current evidence of ocular disease that, in the opinion of the investigator, may confound assessment of visual function

Design outcomes

Primary

MeasureTime frame
- Best corrected E-ETDRS visual acuity - Color test results - Visual field sensitivity measured by static perimetry with topographic analysis (Hill of Vision) - Stereo color fundus photography - Fundus autofluorescence photography - Ellipsoid zone (EZ) area as measured by Optical Coherence Tomography - Retinal function using full-field Electroretinography (ERG) amplitudes and timing in response to rod- and cone-specific stimuli - Dark Adaptation Thresholds (DAT)

Secondary

MeasureTime frame
None

Countries

Netherlands

Contacts

Public ContactDH Wijn

Radboud Universitair Medisch Centrum

poli.kno@radboudumc.nl024 361 35 06

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026